Reply to the Editor  by Marcheix, Bertrand & Cartier, Raymond
Although this study summarizes an ini-
tial experience, we thank the authors for
sharing with us their results and for their
contribution to this important new field of
interventional therapy.
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Does the method of lung
preservation influence outcome
after transplantation? An
analysis of 681 consecutive
procedures
To the Editor:
We read with great interest the study by Ga-
nesh and colleagues1 that compared various
graft preservation methods in lung trans-
plantation. The authors rigorously assessed
the association between the lung preserva-
tion method and the posttransplant survival
up to 3 years in a large cohort of patients;
they failed to detect any association. How-
ever, we think that the way the graft ische-
mic time was calculated and included in
the analysis may have biased the results.
Graft ischemic time has been shown to be
associated with survival after lung trans-
plantation in several studies.2,3 In these
studies, in case of double-lung transplanta-
tion, graft ischemic time was defined as
the time from donor crossclamping to reper-
fusion of the second lung. In their study, Ga-
nesh and colleagues considered ischemic
time as the time from donor crossclamping
to reperfusion of the first lung only. This
could lead to incorrect adjustment. Second,
we have found that the relationship between
graft ischemic time and survival could be of
exponential form, the graft ischemic time al-
tering the survival of recipients only when it
exceeds 4 to 6 hours.3 Unfortunately, the au-
thors did not report on the distribution of
graft ischemic time by the preservation
method. Given the incidence of local donors
in their cohort, we suspect that graft ische-
mic time was rather short in most patients.
This point is essential, because the efficacy
of different graft preservation solutions may
prove similar for short graft ischemic times
and different for longer ischemic times.
We think that the analysis of adjusted sur-
vival by preservation solution for patients
with a long ischemic time would have
yielded more insight in the efficacy of pres-
ervation solutions. However, the number of
patients in each group would have probably
been low, precluding powerful statistical
analysis. The authors report no interaction
between the graft ischemic time and the
preservation solution used; however, inter-
action testing is not powerful enough. We
agree that the way to definitely answer this
question is to conduct a randomized con-
trolled trial, and we think that such a trial
should stratify patients by the expected graft
ischemic time or the surgical procedure (sin-
gle vs bilateral lung transplantation).
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Reply to the Editor:
We appreciate the comments made by Tha-
but and colleagues on our article on lung
preservation.1 We agree that graft ischemia
time may be an important predictor to sur-
vival after lung transplantation, particularly
if this is particularly prolonged. The study
by Novick and colleagues2 did not find
any influence of graft ischemia time alone
on survival, but there was a significant
Letters to the EditorReply to the Editor:
We appreciate the authors’ concerns about
the quality of ourwork published the Journal
of Thoracic and Cardiovascular Surgery.
We totally agree with the two underlined
points and we would like to simply answer
the two questions.
It is true that prosthesis sizing is an
important issue. All the reported patients
had an aortic annulus diameter ranging
from 20 to 23 mm. Smaller and larger annuli
were considered as contraindicated so as to1408 The Journal of Thoracic and Cardallow correct anchorage of the prosthesis
in the annulus.
All the patients had the echographic
aspect of a tricuspid aortic valve. We can-
not answer Zegdi and colleagues because
we do not have any experience with per-
cutaneous aortic valve implantation in
bicuspid valves. Bicuspid valves are gen-
erally more calcified than tricuspid valves
and frequently come with a moderate
dilatation of the aorta. They are less
favourable for currently used percutaneous
aortic valves.
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